The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Amid shifting momentum within the chemicals sector, Eastman Chemical (EMN) is emerging as a potential candidate for value-oriented investors. According to reports, a Discounted Cash Flow (DCF) model indicates a fair value of $134.03 for the stock, suggesting it is significantly undervalued relative to its market price of $74.12. This assessment follows a three-month decline in share price despite recent short-term gains, prompting a re-evaluation of the company's intrinsic value versus the current market narrative.
When compared to industry peers, a valuation gap is evident; companies such as Celanese (CE) and Dow Inc (DOW) are trading at multiples that reflect similar sector headwinds, yet the discrepancy in EMN appears more pronounced per market data. In its Q1 2024 earnings report, Eastman posted adjusted EPS of $1.61, beating analyst estimates of $1.45 (per company filings), which supports the case for operational resilience despite sluggish global demand in certain end markets.
Sign in to access this content
Sign InTechnically, EMN closed at $74.12 (as of May 23, 2026), a level traders are watching for signs of price stabilization. Looking ahead, investors should monitor global industrial production data, such as China's 4.1% growth reported on May 18 (per the economic calendar), as these figures directly impact demand for specialized chemical products and could serve as a catalyst for price recovery.